Selective, reversible competitive dipeptidyl peptidase IV (DP IV) inhibitor (Ki = 130 nM). Inhibits degradation of GIP and GLP-1, enhancing insulin secretion. Improves glucose tolerance, insulin sensitivity and b-cell glucose responsiveness in diabetic fatty rats following oral administration.
Sold with the permission of Probiodrug.
|Storage||Desiccate at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Pederson et al (1998) Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47 1253 PMID: 9703325
Pospisilik et al (2002) Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat. Diabetes 51 2677 PMID: 12196458
View Related Products by Product Action
Keywords: P32/98, P32/98 supplier, Isoleucyl, thiazolidide, Other, Proteases, 2136, Tocris Bioscience
Citations for P32/98
Citations are publications that use Tocris products.
Currently there are no citations for P32/98.
Reviews for P32/98
There are currently no reviews for this product. Be the first to review P32/98 and earn rewards!
Have you used P32/98?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
New Product Guide (Spring/Summer 2018)New
Our new product guide highlights over 200 new products added to the Tocris Bioscience range during the second half of 2017.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Cell Metabolism
- Fluorescent Imaging
- Signal Transduction
- Stem Cells